1. ICH Harmonised tripartite guideline. detection of toxicity to reproduction for medicinal products & toxicity to male fertility S5(R2). http://www.ich.org/fileadmin/Public_Web_Site/ICH_Products/Guidelines/Safety/S5/Step4/S5_R2__Guideline.pdf (accessed 04.01.16).
2. ICH Final Concept Paper S5(R3) Detection of Toxicity to Reproduction for Medicinal Products & Toxicity to Male Fertility. http://www.ich.org/fileadmin/Public_Web_Site/ICH_Products/Guidelines/Safety/S5/S5_R3__Final_Concept_Paper_27Mar2015.pdf (accessed 01.07.16).
3. Guidelines for Reproduction Studies for Safety Evaluation of Drugs for Human Use;FDA,1966
4. ICH Harmonised tripartite guideline preclinical safety evaluation of biotechnology-derived pharmaceuticals. S6(R1). http://www.ich.org/fileadmin/Public_Web_Site/ICH_Products/Guidelines/Safety/S6_R1/Step4/S6_R1_Guideline.pdf (accessed 02.17.16).
5. ICH Guidance for Industry S9 Nonclinical Evaluation for Anticancer Pharmaceuticals. http://www.fda.gov/downloads/Drugs/…/Guidances/ucm085389.pdf (accessed 02.17.16).